Detecting apelin isoforms in human plasma using LC-MS/MS

21 March 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The apelin peptides are a family of widely expressed peptide hormones that act as the ligand for the G-protein coupled receptor APJ. Apelin plays a significant role in cardiovascular health, neuroprotection, glucose metabolism, kidney function, and potentially tumor growth. These pleiotropic biological effects make apelin peptides potentially useful biomarkers or potential therapeutic agents. Signal transduction by apelin’s binding protein APJ can be heavily biased by different apelin isoforms and lead to different biological effects. This isoform-dependent signaling necessitates that apelin peptides are measured using an analytical approach capable of detecting each apelin isoform in a sensitive, specific, and robust manner to understand apelins biological activities. The standard methods for measuring apelin rely on immunoaffinity assays, which are not able to reliably distinguish between apelin isoforms. Here we demonstrate an ultra-high-performance liquid chromatography – tandem mass spectrometry method for the quantification of apelin peptide isoforms apelin-12, apelin-13, [Pyr1]-apelin-13, and apelin-17 in human plasma samples. This method is capable of detecting endogenous apelin in human plasma with a limit of detection in the picomolar range and a coefficient of variation of less than 20%. Using this method specific apelin peptides can be detected in plasma from human subjects allowing for future investigations of apelins in health and disease.

Keywords

Apelin Isoforms
Human Plasma
Liquid Chromatography Mass Spectrometry

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.